-
Product Insights
GRT Jewellers Solar PV Park
GRT Jewellers Solar PV Park is a solar PV project located in Tamil Nadu, India. The project is owned and developed by GRT Jewellers Pvt Ltd. The project is currently under construction. Empower your strategies with our GRT Jewellers Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain...
-
Product Insights
GRT Jewellers Virudhunagar Solar PV Park
GRT Jewellers Virudhunagar Solar PV Park is a solar PV project located in Tamil Nadu, India. The project is owned by GRT Jewellers Pvt Ltd. The project came online in 2019. Empower your strategies with our GRT Jewellers Virudhunagar Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain...
-
Product Insights
GRT Jewellers Kannakapura Solar PV Park
GRT Jewellers Kannakapura Solar PV Park is a solar PV project located in Karnataka, India. The project is owned and developed by GRT Jewellers Pvt Ltd. The project came online in 2017. Empower your strategies with our GRT Jewellers Kannakapura Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cebranopadol in Substance (Drug) Abuse
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Cebranopadol in Substance (Drug) Abuse Drug Details: Cebranopadol (GRT-6005) is under development for the treatment...
-
Company Profile
Gritstone Bio Inc – Company Profile
Gritstone Bio Inc (Gritstone), formerly Gritstone Oncology Inc, is a clinical-stage biotechnology company. The company discovers, develops, manufactures, and delivers vaccine-based immunotherapy candidates against cancer and infectious diseases. It develops personalized cancer vaccines designed to direct a robust immune response to neoantigens by leveraging its artificial intelligence Gritstone EDGE platform. Gritstone’s cancer vaccines product pipeline includes GRANITE and SLATE for solid tumors; and prophylactic samRNA (CORAL), HIV Therapeutic vaccine, and other flu, multi-respiratory, papillomavirus (HPV) eradication pathogens. The company designs...
Add to Basket -
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – cebranopadol
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry cebranopadol Drug Details Cebranopadol (GRT-6005) is under development for the treatment of cancer pain...